JL

Jian Luo

NB Ngm Biopharmaceuticals: 13 patents #6 of 43Top 15%
ME Metabolex: 8 patents #6 of 50Top 15%
SP Shaman Pharmaceuticals: 6 patents #2 of 29Top 7%
Stanford University: 4 patents #598 of 5,197Top 15%
DC Diatex Co.: 4 patents #1 of 25Top 4%
AM Amgen: 3 patents #987 of 2,867Top 35%
DA Department Of Veterans Affairs: 1 patents #199 of 615Top 35%
CU Columbia University: 1 patents #1,151 of 2,492Top 50%
FU Fitel Usa: 1 patents #112 of 266Top 45%
📍 Albany, CA: #14 of 590 inventorsTop 3%
🗺 California: #12,236 of 386,348 inventorsTop 4%
Overall (All Time): #85,768 of 4,157,543Top 3%
38
Patents All Time

Issued Patents All Time

Showing 1–25 of 38 patents

Patent #TitleCo-InventorsDate
11564972 Methods of using compositions comprising variants of FGF19 polypeptides for treating primary biliary cirrhosis in a subject Lei Ling 2023-01-31
11141460 Methods for treatment of bile acid-related disorders and prediction of clinical sensitivity to treatment of bile acid-related disorders Alexander M. DePaoli, Hui Tian 2021-10-12
11103554 Methods of using compositions comprising variants of FGF19 polypeptides for reducing bile acid synthesis in a subject having cirrhosis Lei Ling 2021-08-31
10744185 Methods of using variants of FGF19 polypeptides for the treatment of pruritus Lei Ling, Hui Tian 2020-08-18
10688130 Methods and compositions for treating aging-associated conditions Anton Wyss-Coray, Saul A. Villeda, Joseph M. Castellano, Jinte Middeldorp, Martin S. Angst 2020-06-23
10688154 Methods of neuroprotection involving macrophage colony stimulating factor receptor agonists Anton Wyss-Coray 2020-06-23
10434144 Methods for treatment of bile acid-related disorders and prediction of clinical sensitivity to treatment of bile acid-related disorders Alexander M. DePaoli, Hui Tian 2019-10-08
9974833 Methods of using compositions comprising variants and fusions of FGF19 polypeptides for modulating bile acid homeostasis in a subject having pregnancy intrahepatic cholestasis Lei Ling 2018-05-22
9925242 Methods of using compositions comprising variants and fusions of FGF19 polypeptides for treatment of nonalcoholic steatohepatitis Lei Ling 2018-03-27
9895416 Methods of using compositions comprising variants and fusions of FGF19 polypeptides for modulating bile acid homeostasis in a subject having cholestasis Lei Ling 2018-02-20
9889177 Methods of using compositions comprising variants and fusions of FGF19 polypeptides for modulating bile acid homeostasis in a subject having primary sclerosing cholangitis Lei Ling 2018-02-13
9889178 Methods of using compositions comprising variants and fusions of FGF19 polypeptides for modulating bile acid homeostasis in a subject having nonalcoholic steatohepatitis Lei Ling 2018-02-13
9878009 Methods of using compositions comprising variants and fusions of FGF19 polypeptides for modulating bile acid homeostasis in a subject having error of bile acid synthesis Lei Ling 2018-01-30
9878008 Methods of using compositions comprising variants and fusions of FGF19 polypeptides for modulating bile acid homeostasis in a subject having bile acid diarrhea or bile acid malabsorption Lei Ling 2018-01-30
9796674 Benzyl urea derivatives for activating TGF-beta signaling Mary J. Tanga, Laura Ellen Downs Beaulieu, Anton Wyss-Coray, Carol Green, Hui Zhang 2017-10-24
9770486 Methods of neuroprotection involving macrophage colony stimulating factor receptor agonists Anton Wyss-Coray 2017-09-26
9273107 Uses and methods for modulating bile acid homeostasis and treatment of bile acid disorders and diseases Lei Ling 2016-03-01
9161968 Methods of neuroprotection involving macrophage colony stimulating factor receptor agonists Anton Wyss-Coray 2015-10-20
8481597 Use of (-) (3-trihalomethylphenoxy) (4-halophenyl) acetic acid derivatives for treatment of insulin resistance, type 2 diabetes, hyperlipidemia and hyperuricemia Kenneth L. Luskey 2013-07-09
8354448 Use of (−)(3-trihalomethylphenoxy)(4-halophenyl) acetic acid derivatives for treatment of type 2 diabetes Kenneth L. Luskey 2013-01-15
8329749 Use of (−) (3-trihalomethylphenoxy) (4-halophenyl) acetic acid derivatives for treatment of hyperuricemia Kenneth L. Luskey 2012-12-11
8030354 Substituted biphenyl GPR40 modulators Sean P. Brown, Qiong Cao, Paul John Dransfield, Xiaohui Du, Zice Fu +22 more 2011-10-04
7816367 Compounds, pharmaceutical compositions and methods for use in treating metabolic disorders Michelle Akerman, Jonathan Houze, Daniel C. H. Lin, Jiwen Liu, Julio C. Medina +11 more 2010-10-19
7811593 Pharmaceutical composition with combined active agents and methods for using the same Hui Wu 2010-10-12
7649110 Compounds, pharmaceutical compositions and methods for use in treating metabolic disorders Michelle Akerman, Jonathan Houze, Daniel C. H. Lin, Jinqian Liu, Jiwen Liu +11 more 2010-01-19